Antonio Pardo, MD

  • 1Article
  • 9.8KReads
  • 2022Active
  • 7Collaborators
  • 6Citations

About

Antonio Pardo, MD is affiliated with Tris Pharma, Inc., Monmouth Junction, New Jersey. Antonio Pardo has contributed 1 peer-reviewed article published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders in 2022. Their work focuses on Attention-Deficit/Hyperactivity Disorder.

Publications

JCP
Amphetamine Extended-Release Tablets for Adult ADHD
Original Research

Amphetamine Extended-Release Tablets for Adult ADHD

July 20, 2022

Treating attention-deficit/hyperactivity disorder (ADHD) in adults can improve long-term outcomes, such as reducing suicidal behavior and mortality. This study evaluated the efficacy and safety of amphetamine extended-release tablets in...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe